HCA HEALTHCARE INC (HCA) Stock Analyst Earnings Estimates
NYSE:HCA - New York Stock Exchange, Inc. - US40412C1018 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 60.233B 2.52% | 64.968B 7.86% | 70.603B 8.67% | 75.506B 6.94% | 79.563B 5.37% | 85.153B 7.03% | 90.682B 6.49% | 95.055B 4.82% | 99.486B 4.66% | 104.109B 4.65% | 108.877B 4.58% | |
| EBITDA YoY % growth | 12.022B -4.06% | 12.704B 5.67% | 13.859B 9.09% | 14.856B 7.19% | 15.656B 5.39% | 16.705B 6.70% | 17.776B 6.41% | 18.739B 5.42% | 19.622B 4.71% | 20.543B 4.69% | 21.494B 4.63% | |
| EBIT YoY % growth | 9.053B -6.46% | 9.627B 6.34% | 10.547B 9.56% | 11.336B 7.48% | 11.998B 5.84% | 12.469B 3.93% | 13.333B 6.93% | 14.08B 5.60% | 14.747B 4.74% | 15.442B 4.71% | 16.159B 4.64% | |
| Operating Margin | 15.03% | 14.82% | 14.94% | 15.01% | 15.08% | 14.64% | 14.70% | 14.81% | 14.82% | 14.83% | 14.84% | |
| EPS YoY % growth | 16.90 -3.43% | 18.66 10.41% | 22.12 18.54% | 24.98 12.94% | 28.01 12.11% | 31.45 12.28% | 35.72 13.60% | 39.66 11.03% | 43.45 9.55% | 47.47 9.25% | 51.59 8.68% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 5.82 -1.83% | 6.28 13.54% | 5.69 13.15% | 7.27 29.04% | 6.64 14.12% | 7.00 11.51% | 6.34 11.42% | 7.99 9.93% | 7.59 14.25% | 8.12 15.91% | 7.33 15.56% | 9.29 16.35% |
| Revenue Q2Q % growth | 18.438B 6.34% | 18.615B 6.42% | 18.642B 6.60% | 19.605B 7.22% | 19.428B 5.37% | 19.551B 5.03% | 19.571B 4.98% | 20.629B 5.22% | 20.462B 5.32% | 20.692B 5.84% | 20.714B 5.84% | 21.745B 5.41% |
| EBITDA Q2Q % growth | 3.577B 6.62% | 3.73B -14.15% | 3.495B -28.18% | 4.043B -34.35% | 3.796B 6.12% | 3.939B 5.60% | 3.694B 5.69% | 4.26B 5.37% | 4.01B 5.64% | 4.237B 7.57% | 3.959B 7.17% | 4.543B 6.64% |
| EBIT Q2Q % growth | 2.686B 4.92% | 2.86B 4.72% | 2.611B 8.34% | 3.149B 10.65% | 2.871B 6.89% | 3.009B 5.21% | 2.747B 5.21% | 3.348B 6.32% | 3.023B 5.29% | 3.241B 7.71% | 2.952B 7.46% | 3.501B 4.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 5.63 -5.06% | 6.18 | -0.55 | -8.93% |
| Q3 2024 Q2Q % growth | 5.03 28.64% | 5.04 | -0.01 | -0.18% |
| Q2 2024 Q2Q % growth | 5.53 28.90% | 4.90 | 0.63 | 12.83% |
| Q1 2024 Q2Q % growth | 5.93 30.91% | 5.04 | 0.89 | 17.74% |
| Q4 2023 Q2Q % growth | 5.93 27.80% | 5.11 | 0.82 | 15.99% |
| Q3 2023 Q2Q % growth | 3.91 -0.51% | 4.02 | -0.11 | -2.67% |
| Q2 2023 Q2Q % growth | 4.29 1.90% | 4.27 | 0.02 | 0.57% |
| Q1 2023 Q2Q % growth | 4.53 9.95% | 3.97 | 0.56 | 14.11% |
| Q4 2022 Q2Q % growth | 4.64 4.98% | 4.83 | -0.19 | -3.95% |
| Q3 2022 Q2Q % growth | 3.93 -14.00% | 3.92 | 0.01 | 0.26% |
| Q2 2022 Q2Q % growth | 4.21 -3.66% | 3.74 | 0.47 | 12.68% |
| Q1 2022 Q2Q % growth | 4.12 -0.48% | 4.29 | -0.17 | -3.99% |
| Q4 2021 Q2Q % growth | 4.42 7.02% | 4.58 | -0.16 | -3.45% |
| Q3 2021 Q2Q % growth | 4.57 138.02% | 4.13 | 0.44 | 10.66% |
| Q2 2021 Q2Q % growth | 4.37 191.33% | 3.19 | 1.18 | 36.81% |
| Q1 2021 Q2Q % growth | 4.14 77.68% | 3.36 | 0.78 | 23.30% |
| Q4 2020 Q2Q % growth | 4.13 33.66% | 3.64 | 0.49 | 13.43% |
| Q3 2020 Q2Q % growth | 1.92 -13.90% | 2.34 | -0.42 | -18.01% |
| Q2 2020 Q2Q % growth | 1.50 -32.13% | -0.39 | 1.89 | 479.94% |
| Q1 2020 Q2Q % growth | 2.33 -21.55% | 2.66 | -0.33 | -12.55% |
| Q4 2019 Q2Q % growth | 3.09 | 3.12 | -0.03 | -0.96% |
| Q3 2019 Q2Q % growth | 2.23 | 2.15 | 0.08 | 3.77% |
| Q2 2019 Q2Q % growth | 2.21 | 2.49 | -0.28 | -11.18% |
| Q1 2019 Q2Q % growth | 2.97 | 2.35 | 0.62 | 26.48% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 18.285B 5.68% | 18.413B | -128M | -0.70% |
| Q3 2024 Q2Q % growth | 17.487B 7.86% | 17.713B | -226M | -1.28% |
| Q2 2024 Q2Q % growth | 17.492B 10.28% | 17.217B | 275M | 1.60% |
| Q1 2024 Q2Q % growth | 17.339B 11.21% | 16.947B | 392M | 2.31% |
| Q4 2023 Q2Q % growth | 17.303B 11.65% | 16.682B | 621M | 3.72% |
| Q3 2023 Q2Q % growth | 16.213B 8.30% | 15.981B | 232M | 1.45% |
| Q2 2023 Q2Q % growth | 15.861B 7.02% | 15.772B | 89M | 0.56% |
| Q1 2023 Q2Q % growth | 15.591B 4.32% | 15.419B | 172M | 1.12% |
| Q4 2022 Q2Q % growth | 15.497B 2.87% | 15.767B | -270M | -1.71% |
| Q3 2022 Q2Q % growth | 14.971B -2.00% | 15.151B | -180M | -1.19% |
| Q2 2022 Q2Q % growth | 14.82B 2.67% | 14.872B | -52M | -0.35% |
| Q1 2022 Q2Q % growth | 14.945B 6.93% | 14.886B | 59M | 0.40% |
| Q4 2021 Q2Q % growth | 15.064B 5.39% | 15.526B | -462M | -2.98% |
| Q3 2021 Q2Q % growth | 15.276B 14.76% | 14.628B | 648M | 4.43% |
| Q2 2021 Q2Q % growth | 14.435B 30.42% | 13.756B | 679M | 4.94% |
| Q1 2021 Q2Q % growth | 13.977B 8.68% | 13.772B | 205M | 1.49% |
| Q4 2020 Q2Q % growth | 14.293B 5.69% | 14.131B | 162M | 1.15% |
| Q3 2020 Q2Q % growth | 13.311B 4.86% | 12.996B | 315M | 2.42% |
| Q2 2020 Q2Q % growth | 11.068B -12.17% | 10.192B | 876M | 8.59% |
| Q1 2020 Q2Q % growth | 12.861B 2.75% | 13.245B | -384M | -2.90% |
| Q4 2019 Q2Q % growth | 13.523B | 13.502B | 21M | 0.16% |
| Q3 2019 Q2Q % growth | 12.694B | 12.623B | 71M | 0.56% |
| Q2 2019 Q2Q % growth | 12.602B | 12.739B | -137M | -1.08% |
| Q1 2019 Q2Q % growth | 12.517B | 12.443B | 74M | 0.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.25% | 0% | -3.14% |
| Revenue | 0% | 0.53% | 0.03% | -0.56% |